Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Takebe

Showing results (301-310 of 304) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 304 results.
Transplantation Proceedings|November 20, 1997
Can fetal xeno whole-organ (heart, lung, kidney, and liver) grafts escape from hyperacute rejection in experimental discordant combinations as compared with adult xenografts?K Tsuji, N Kanai, Y Kise, et al.
Journal of Dental Research|November 23, 2022
Novel Functional Peptide for Next-Generation Vital Pulp TherapyM Watanabe, M Okamoto, S Komichi, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|March 1, 1980
[Clinical studies on KW-1062 (author's transl)]K Mashimo, Y Yamane, S Yamaoka, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|November 1, 1982
[Comparative study of the effectiveness of 9,3"-di-O-acetyl midecamycin (MOM) and josamycin (JM) against acute tonsillitis by double blind method]K Nakagawa, M Koyama, A Saito, et al.
Pageof 31

Showing results (301-310 of 304) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 304 results.
Transplantation Proceedings|November 20, 1997
Can fetal xeno whole-organ (heart, lung, kidney, and liver) grafts escape from hyperacute rejection in experimental discordant combinations as compared with adult xenografts?K Tsuji, N Kanai, Y Kise, et al.
Journal of Dental Research|November 23, 2022
Novel Functional Peptide for Next-Generation Vital Pulp TherapyM Watanabe, M Okamoto, S Komichi, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|March 1, 1980
[Clinical studies on KW-1062 (author's transl)]K Mashimo, Y Yamane, S Yamaoka, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|November 1, 1982
[Comparative study of the effectiveness of 9,3"-di-O-acetyl midecamycin (MOM) and josamycin (JM) against acute tonsillitis by double blind method]K Nakagawa, M Koyama, A Saito, et al.
Pageof 31